Xiang Zhou

17PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersMusic composition and improvisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 11, 2026
Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1.

|Jun 01, 2026
Sunitinib enhances cuproptosis induced by copper ionophores via ROS-ATF3-SLC31A1 axis in thyroid Carcinoma.

|Feb 26, 2026
EZH2 Inhibition Restores Tumor Suppressor SFRP1 Activity by Reprogramming Extrachromosomal Circular DNA Dynamics in Ovarian Cancer.

Tao Han, Qingya Yan, Yaqi Zhang

|Jan 26, 2026
Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer.

Qian Hao, Yu Gan, Xiang Zhou

|Jan 21, 2026
Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer.

Wei Zhao, Qian Hao, Yu Gan

|Sep 01, 2025
YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer.

Tianyi Zhao, Xiaojun Chen, Jiangchun Wu

Pageof 3

Frequent Collaborators

2 joint publications

Qian Hao

1 joint publications

Sarit Larisch

1 joint publications

Shanshan Wang

1 joint publications

Hua Lu